Physician profile
Amanda Olson
NPI 1235625161
$1,563.92
in general payments reported to CMS, 2019-2025
17 companies · $76.09 in 2025
The $76.09 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $435 · 2022: $402 · 2023: $536 · 2024: $116 · 2025: $76.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.55 |
| Education | $164.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $244.83 | 2021 | |
| Axonics, INC. | $240.99 | 2022-2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $216.98 | 2022-2024 | |
| Myovant Sciences INC. | $154.87 | 2021-2022 | |
| Amgen INC. | $99.00 | 2022 | |
| Abbvie INC. | $98.97 | 2022-2025 | |
| Janssen Biotech, INC. | $94.51 | 2021-2023 | Erleada |
| Janssen Scientific Affairs, LLC | $81.93 | 2023 | Erleada |
| Merck Sharp & Dohme LLC | $53.29 | 2022-2023 | Lynparza, Keytruda, Welireg |
| Boston Scientific Corporation | $47.79 | 2022-2025 | General - Kidney Stone Disease |
| 180 Medical, INC. | $42.25 | 2022 | |
| Urovant Sciences INC | $41.85 | 2022 | |
| Sumitomo Pharma America, INC. | $41.82 | 2023 | Gemtesa, Orgovyx |
| Olympus America INC. | $34.29 | 2024-2025 | Itind System |
| Allergan, INC. | $29.49 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $23.54 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.